The first IVERIC bio trade was made in Q4 2019.
Since then Ken Griffin bought shares seven more times and sold shares on seven occasions. The investor sold all their shares in Q3 2023 and doesn't own any shares in IVERIC bio anymore.
Avg closing price
Price range
Sold -300 Thousand shares
Q3 2023
Avg closing price
$39.72
Price range
$39.52
-
$39.95
Increased shares by 1270.7% (+278 Thousand shares)
Q2 2023
Avg closing price
$35.30
Price range
$26.24
-
$39.63
Sold 90.6% shares (-210 Thousand shares)
Q1 2023
Avg closing price
$21.89
Price range
$18.67
-
$24.56
Sold 90.9% shares (-2.33 Million shares)
Q4 2022
Avg closing price
$21.34
Price range
$17.24
-
$23.95
Increased shares by 1403.7% (+2.39 Million shares)
Q3 2022
Avg closing price
$13.13
Price range
$9.40
-
$18.59
Increased shares by 175.9% (+108 Thousand shares)
Q2 2022
Avg closing price
$12.55
Price range
$9.12
-
$18.90
Increased shares by 98.1% (+30.5 Thousand shares)
Q1 2022
Avg closing price
$14.78
Price range
$12.15
-
$16.83
Sold 95.5% shares (-657 Thousand shares)
Q4 2021
Avg closing price
$16.39
Price range
$13.83
-
$18.78
Increased shares by 73.6% (+292 Thousand shares)
Q3 2021
Avg closing price
$10.88
Price range
$7.07
-
$17.50
Sold 55.8% shares (-501 Thousand shares)
Q2 2021
Avg closing price
$6.45
Price range
$5.69
-
$7.17
Sold 25.3% shares (-304 Thousand shares)
Q1 2021
Avg closing price
$6.07
Price range
$5.08
-
$6.90
Increased shares by 2150.4% (+1.15 Million shares)
Q3 2020